Javascript must be enabled to continue!
Abstract 820: Enoxaparin Reverses Ventricular Tachycardia and Torsades de Pointes in Rat Isolated Heart Model
View through CrossRef
Introduction:
Enoxaparin (Enox) is used in cardiovascular emergency and coronary angiography due to its effects on coagulation mechanisms. However, its effect on changing the structure of the exchange-inhibiting peptide present in the sodium-calcium exchanger, leading to the acceleration of its function and withdrawing calcium from the cell in overload situations could lead to a new therapeutic function, where the intracellular calcium overload would be deleterious, as in cardiac arrhythmias and myocardial infarction.
Objective:
To analyze the action of Enox on cardiac arrhythmias induced by ischemia and reperfusion (IR) in isolated rat hearts. Materials and method. Adult Wistar rats were sacrificed, hearts isolated and placed under perfusion in Langhendorf Model with Krebs solution (KS) and monitoring of the electrocardiogram. After 30 minutes in sinus rhythm, ischemia was performed with discontinuation of the KS for 5 min and then reconnected. They were divided into 2 groups: Control (n = 10), with IR without medication and Enox Group, with infusion of 2mg / kg, in the cannula that perfuses the heart, soon after initiation and support for 30 seconds of Ventricular Tachycardia (VT) or Torsade de Pointes (TP). In case of reversal of the arrhythmia, a new arrhythmia induction will be attempted with the same protocol. Monitoring is continued until asystole or completion scheduled for 60 minutes of experimentation.
Results:
The control group presented VT in 70% of hearts and total atrioventricular block (TAVB) in 30% of hearts, followed by asystole after 7 minutes in 100% of hearts, and no further attempt of ischemia was possible. In the Enox group, 60% of VT, 30% of TP and 10% of TAVB were observed. All arrhythmias were reversed between 10 and 15 seconds after infusion of Enox, with return and maintenance of sinus rhythm after medication. In this group, a new attempt was made to induce arrhythmia due to IR without success after 10 minutes of interruption of the arrhythmia by Enox and sinus rhythm was maintained until the interruption of the experimental protocol.
Conclusion:
Enoxaparin reverses arrhythmias triggered by IR, with its effect prolonging and protecting new events after infusion, as well as decreasing organ mortality in isolated hearts of rats.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract 820: Enoxaparin Reverses Ventricular Tachycardia and Torsades de Pointes in Rat Isolated Heart Model
Description:
Introduction:
Enoxaparin (Enox) is used in cardiovascular emergency and coronary angiography due to its effects on coagulation mechanisms.
However, its effect on changing the structure of the exchange-inhibiting peptide present in the sodium-calcium exchanger, leading to the acceleration of its function and withdrawing calcium from the cell in overload situations could lead to a new therapeutic function, where the intracellular calcium overload would be deleterious, as in cardiac arrhythmias and myocardial infarction.
Objective:
To analyze the action of Enox on cardiac arrhythmias induced by ischemia and reperfusion (IR) in isolated rat hearts.
Materials and method.
Adult Wistar rats were sacrificed, hearts isolated and placed under perfusion in Langhendorf Model with Krebs solution (KS) and monitoring of the electrocardiogram.
After 30 minutes in sinus rhythm, ischemia was performed with discontinuation of the KS for 5 min and then reconnected.
They were divided into 2 groups: Control (n = 10), with IR without medication and Enox Group, with infusion of 2mg / kg, in the cannula that perfuses the heart, soon after initiation and support for 30 seconds of Ventricular Tachycardia (VT) or Torsade de Pointes (TP).
In case of reversal of the arrhythmia, a new arrhythmia induction will be attempted with the same protocol.
Monitoring is continued until asystole or completion scheduled for 60 minutes of experimentation.
Results:
The control group presented VT in 70% of hearts and total atrioventricular block (TAVB) in 30% of hearts, followed by asystole after 7 minutes in 100% of hearts, and no further attempt of ischemia was possible.
In the Enox group, 60% of VT, 30% of TP and 10% of TAVB were observed.
All arrhythmias were reversed between 10 and 15 seconds after infusion of Enox, with return and maintenance of sinus rhythm after medication.
In this group, a new attempt was made to induce arrhythmia due to IR without success after 10 minutes of interruption of the arrhythmia by Enox and sinus rhythm was maintained until the interruption of the experimental protocol.
Conclusion:
Enoxaparin reverses arrhythmias triggered by IR, with its effect prolonging and protecting new events after infusion, as well as decreasing organ mortality in isolated hearts of rats.
Related Results
Torsades de Pointes Following Ondansetron Administration: A Case Report with literature review
Torsades de Pointes Following Ondansetron Administration: A Case Report with literature review
Abstract
Introduction
Ondansetron blocks human ether-à-go-go-related gene (hERG) potassium channels, causing QT prolongation and risk of torsades de pointes (TdP). Despite its wide...
Population Pharmacokinetics of Enoxaparin During the Antenatal Period
Population Pharmacokinetics of Enoxaparin During the Antenatal Period
Abstract
Abstract 503
The optimal dosing strategy of low molecular weight heparins (LMWH) for the treatment of antenatal venous thromboembolism (VTE) ...
Case report: Para Hisian Atrial Tachycardia
Case report: Para Hisian Atrial Tachycardia
Atrial tachycardia accounts for around 10% of supraventricular tachycardias (1). Atrial tachycardia can either be focal or macrorenentrant. Focal AT usually start at a focal p...
Ketorolac and Enoxaparin Affect Arterial Thrombosis and Bleeding in the Rabbit
Ketorolac and Enoxaparin Affect Arterial Thrombosis and Bleeding in the Rabbit
Background
Nonsteroidal anti-inflammatory drugs (NSAIDs) may interfere with hemostasis during the perioperative period, and the combination of NSAID and enoxaparin coul...
Runahead threads
Runahead threads
Los temas de investigación sobre multithreading han ganado mucho interés en la arquitectura de computadores con la aparición de procesadores multihilo y multinucleo. Los procesador...
Pharmacoequivalence of Enoxaparin and Contaminated Enoxaparin
Pharmacoequivalence of Enoxaparin and Contaminated Enoxaparin
Abstract
Introduction: Earlier this year, heparin was found to be contaminated with a non-heparin sulfated polymer identified as oversulfated chondroitin sulfate (OS...
Treatment of Deep Vein Thrombosis with Enoxaparin in Pediatric Cancer Patients Receiving Chemotherapy.
Treatment of Deep Vein Thrombosis with Enoxaparin in Pediatric Cancer Patients Receiving Chemotherapy.
Abstract
Thrombosis is a known risk in pediatric patients with leukemia. This risk is increased when L-asparaginase is administered. However, children with cancer ma...
Cellular mechanisms of early tachycardia-induced ventricular dysfunction in the human heart
Cellular mechanisms of early tachycardia-induced ventricular dysfunction in the human heart
Abstract
Background
Tachycardia-induced cardiomyopathy (TCM) is a reversible form of ventricular dysfunction caused by persisten...

